Dozens of US workers taking anti-anthrax drugs

by Marilynn Marchione
This undated file electronmicrograph from the official U.S. Department of Defense anthrax information Web Site shows Bacillus anthracis vegetative cells in a monkey spleen. Anthrax is an infectious disease caused by the spore-forming bacteria Bacillus anthracis. The Centers for Disease Control and Prevention said Thursday, June 19, 2014, that some of its staff in Atlanta may have been accidentally exposed to dangerous anthrax bacteria because of a safety problem at some of its labs. (AP Photo/Anthrax Vaccine Immunization Program, File)

The U.S. Centers for Disease Control and Prevention says at least 52 workers are taking antibiotics as a precaution because of a lab safety problem that may have accidentally exposed them to anthrax.

So far, the CDC's occupational health clinic has seen 54 out of 86 potentially exposed employees. Only two have refused antibiotic treatment, which can cut the chances of infection after exposure to the germ. The CDC says 27 of them also began receiving an .

The safety lapse occurred when a high-level biosecurity lab failed to completely inactivate anthrax samples sent to less secure labs for further research. The problem was discovered last Friday, and the CDC revealed it on Thursday.

Related Stories

CA lab revisits safety steps after researcher dies

date May 04, 2012

(AP) -- Lab workers at the San Francisco Veterans Affairs medical center will be urged to get vaccinations for the diseases they study as a precaution as investigators continue looking into a researcher's death after he ...

Recommended for you

Combined drug treatment combats kidney disease

date 3 hours ago

A recent discovery by drug researchers whereby coupling specific cell membrane receptors has altered kidney cell function has triggered a re-think of how to treat chronic kidney disease (CKD) more effectively.

Active substance targeting dreaded hospital germs

date 3 hours ago

In the German Center for Infection Research (DZIF), scientists have conducted clinical studies on an active substance against the dreaded hospital pathogen Staphylococcus aureus: a highly effective protein from bacteriophages ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.